Nanoparticle Dissolution Testing Solution from Agilent Technologies

In the Lab eNewsletter, Pharmaceutical Technology's In the Lab eNewsletter 12-02-2020, Volume 15, Issue 12

The system gives R&D formulation chemists the ability to manufacture new formulations sooner, while allowing manufacturing teams to supply reliable batches of new drug products for commercial sale in an automated and compliant manner.

The NanoDis System for nanoparticle dissolution testing from Agilent Technologies combines Agilent’s instrumentation and software to provide a system that is automatable and auditable.

The system gives R&D formulation chemists the ability to manufacture new formulations sooner, while allowing manufacturing teams to supply reliable batches of new drug products for commercial sale in an automated and compliant manner.

"Agilent's introduction of the NanoDis System is significant in that it is the first nanoparticle testing solution that allows methods to be easily transferred from R&D to QC, supporting scientists in meeting the requirements of United States Pharmacopeia," said Michael Frank, associate vice-president of global marketing for Agilent’s Liquid Phase Separation division, in a Nov. 23, 2020 company press release. "The NanoDis System can be universally implemented, therefore ensuring that our customers' global laboratory locations deliver the same results every time. Additionally, the NanoDis System is an end-to-end, single-vendor solution that is fully supported by a dedicated global team."

Source: Agilent